ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 131 • 2014 ACR/ARHP Annual Meeting

    Detection of Synovitis and Erosions with an Automated Ultrasound System: Data from a Prospective Cohort with Early and Established RA

    Matthias Witt1, Janette Frielinghausen2, Jan Leipe2, Hendrik Schulze-Koops2, Ruediger Mueller3 and Mathias Grunke2, 1Division of Rheumatology and Clinical Immunology, University of Munich, Munich, Germany, 2Division for Rheumatology, Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany, 3Rheumatology, Kantonspital St. Gallen, St. Gallen, Switzerland

    Background/Purpose: Arthrosonography has proven to be a sensitive and reliable, but time-consuming method for the evaluation of arthritis in small joints of patients with RA…
  • Abstract Number: 130 • 2014 ACR/ARHP Annual Meeting

    Inter-Rater Reliability of the US-7 Score in a Population of Volunteers: Is a Post-Hoc Analysis of Still Images Comparable to the Dynamic Analysis? Results from the German “Rheuma-Truck” Cohort

    Dr. Philipp Sewerin1, Dr. Stefan Vordenbäumen2, Sarah Ohrndorf3, Marina Backhaus3, Dr. Oliver Sander2, Prof. Dr. Matthias Schneider4, Prof. Dr. Benedikt Ostendorf1 and Aiko Liedmann5, 1Department of Rheumatology, Univ. Duesseldorf, Düsseldorf, Germany, 2Department for Rheumatology, Univ. Duesseldorf, Düsseldorf, Germany, 3Rheumatology/Immunology, Charite University Hospital, Berlin, Germany, 4Department of Rheumatology, Univ. Duesseldorf, Duesseldorf, Germany, 5Univ. Duesseldorf, Düsseldorf, Germany

    Background/Purpose To investigate the value of a follow-up analysis of ultrasonographic still images versus dynamic investigation using the US-7 ultrasound score. Methods “Rheuma-Truck” was a…
  • Abstract Number: 129 • 2014 ACR/ARHP Annual Meeting

    Seven Joints Ultrasound Scoring System May be Useful and Effective in Assessing Disease Activity in Patients with Rheumatoid Arthritis in the State of Remission in Daily Clinical Practice

    Petra Hanova1, Jakub Zavada1, Jana Hurnakova1, Martin Klein1, Olga Sleglova1, Marta Olejarova1, Martin Komarc2, Ladislav ŠEnolt1 and Karel Pavelka3, 1Institute of Rheumatology, Charles University, 1st Medical Faculty, Prague, Czech Republic, 2Institute of Biophysics and Informatics, Prague, Czech Republic, 3Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University in Prague, Prague, Czech Republic

    Background/Purpose: To evaluate if the 7-joint ultrasound scoring system (US7) is able to find synovitis in patients in remission of RA.   Methods: Patients with rheumatoid…
  • Abstract Number: 128 • 2014 ACR/ARHP Annual Meeting

    A Rapid 4- Joint Ultrasonographic Score to Daily Monitoring Disease Activity in Patients with Rheumatoid Arthritis: Validity and Sensitivity to Change

    Tomas Cazenave1, Christian A. Waimann2, Gustavo Citera3 and Marcos G. Rosemffet4, 1Junin 519 1ero B, IREP, Buenos Aires, Argentina, 2Rheumatology, Hospital Olavarria, Olavarria, Argentina, 3Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, 4Rheumatology, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina

    Background/Purpose Ultrasound has demonstrated to be a sensitivity and specific tool to assess patients with Rheumatoid Arthritis (RA). However, the feasibility of this technology in…
  • Abstract Number: 127 • 2014 ACR/ARHP Annual Meeting

    Metacarpophalangeal Cartilage Loss in Rheumatoid Arthritis. a Simple and Fast Ultrasonographic Assessment Comparing Patients and Healthy Controls

    Tomas Cazenave1, Christian A. Waimann2, Marwin Gutierrez3, Emilio Filippucci4, Gustavo Citera5 and Marcos G. Rosemffet1, 1Rheumatology, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, 2Rheumatology section, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, 3Università Politecnica delle Marche, Jesi, Italy, 4Department of Rheumatology, University of Ancona, Jesi, Italy, 5Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina

    Background/Purpose There is evidence supporting the use of ultrasonography (US) as a valid and reliable imaging tool to evaluate cartilage in patients with arthritis. The…
  • Abstract Number: 126 • 2014 ACR/ARHP Annual Meeting

    Asymptomatic Versus Symptomatic Ankle Joints in Rheumatoid Arthritis: A High Resolution B-Mode and Power Doppler Ultrasound Study

    Mohammed Alsuwaidi1, Boris P. Ehrenstein1, Wolfgang Hartung1 and Martin Fleck2, 1Rheumatology & Clinical Immunology, Asklepios Clinic Bad Abbach, Bad Abbach, Germany, 2Internal Medicine I, University Medical Center of Regensburg, Regensburg, Germany

    Background/Purpose: Despite a crucial role for RA patients’ mobility, the ankle joints are frequently clinically neglected, and omitted in activity scoring systems including DAS 28.…
  • Abstract Number: 125 • 2014 ACR/ARHP Annual Meeting

    PD Signal Detected By Ultrasonography Relates to Joint Destruction in Rheumatoid Arthritis Under Biologics Therapy in Real World

    Maasa Hama1, Yumiko Sugiyama1, Naomi Tsuchida1, Yosuke Kunishita1, Daiga Kishimoto1, Reikou Kamiyama1, Kaoru Minegishi-Takase1, Ryusuke Yoshimi1, Yohei Kirino2, Mitsuhiro Takeno3, Atsuhisa Ueda1 and Yoshiaki Ishigatsubo1, 1Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan, 2Yokohama City University Graduate School of Medicine, Yokohama, Japan, 3Clinical Laboratory Department, Yokohama City University Hospital, Yokohama, Japan

    Background/Purpose: Biologic DMARD (biologics) therapy for rheumatoid arthritis (RA) strongly suppresses joint destruction regardless of its efficacy for disease activity. On the contrary power Doppler…
  • Abstract Number: 124 • 2014 ACR/ARHP Annual Meeting

    Ultrasound Power Doppler Findings in the Wrists and Hands Joints of Anti-CCP Antibody Positive Individuals with Non-Specific Musculoskeletal Symptoms and the Development of Inflammatory Arthritis

    Jackie L. Nam, Laura Hunt, Elizabeth M.A. Hensor, Philip G. Conaghan, Richard J. Wakefield and Paul Emery, NIHR-Leeds Musculoskeletal Biomedical Research Unit and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom

    Background/Purpose The use of musculoskeletal ultrasound is increasing in rheumatology practice. Recently we have shown that use of power Doppler signal (PD) on ultrasound in…
  • Abstract Number: 123 • 2014 ACR/ARHP Annual Meeting

    Combination with Joint Power Doppler Signals with Anti-Citrullinated Peptide Antibody Predicts Joint Destruction in Rheumatoid Arthritis

    Yohei Kirino1, Maasa Hama1, Kaoru Minegishi-Takase1, Yosuke Kunishita1, Daiga Kishimoto1, Ryusuke Yoshimi1, Yukiko Asami1, Atsushi Ihata2, Shigeru Ohno3, Atsuhisa Ueda1, Mitsuhiro Takeno4 and Ishigatsubo Yoshiaki1, 1Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan, 2Department of Rheumatology, Yokohama Minami Kyosai Hospital, Yokohama, Japan, 3Center for Rheumatic Diseases, Yokohama City University Medical Center, Yokohama, Japan, 4Clinical Laboratory Department, Yokohama City University Hospital, Yokohama, Japan

    Background/Purpose ,  Categorizing RA patients who require intensive treatments is highly warranted to optimize the therapy and to avoid overtreatments.  We here evaluated the use…
  • Abstract Number: 122 • 2014 ACR/ARHP Annual Meeting

    The Use of Ultrasound to Detect Residual Joint Inflammation in Patients with Rheumatoid Arthritis in Clinical Disease Remission

    Gurjit S. Kaeley1, Midori Jane Nishio2, Janak Goyal3, Daryl MacCarter4, Alvin Wells5, Anabela Cardoso6, Shufang Liu7, Jasmina Kalabic8 and Hartmut Kupper8, 1College of Medicine, University of Florida, Jacksonville, FL, 2Diablo Clinical Research, Walnut Creek, CA, 3Raritan Bay Medical Center, Perth Amboy, NJ, 4Coeur d'Alene Arthritis Clinic, Coeur d'Alene, ID, 5Rheumatology & Immunotherapy Center, Franklin, WI, 6AbbVie, Amadora, Portugal, 7AbbVie Inc., North Chicago, IL, 8AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany

    Background/Purpose Patients (pts) with rheumatoid arthritis (RA), who achieve clinical disease remission by treatment with disease- modifying agents may have residual joint inflammation and vascularization,…
  • Abstract Number: 121 • 2014 ACR/ARHP Annual Meeting

    Predictors of Persistence of Power Doppler Ultrasound Synovitis in Rheumatoid Arthritis Patients in Clinical Remission

    Nathalie Filippi1, Cédric Lukas2, Jacques Morel3, Bernard Combe4 and Gael Mouterde5, 1Rheumatology, Hopital Lapeyronie, Montpellier, France, 2Immuno-Rhumatologie, Hopital Lapeyronie, Montpellier, France, 3Department of Rheumatology, Hôpital Lapeyronie, Montpellier, France, 4Immuno-Rhumatologie, Hôpital Lapeyronie, Montpellier, France, 5Immunologie Rhumatologie, Hopital Lapeyronie, Montpellier, France

    Background/Purpose Ultrasound (US) is a sensitive tool for the evaluation of joint inflammation in patients with RA, and can detect synovitis even when clinical remission…
  • Abstract Number: 120 • 2014 ACR/ARHP Annual Meeting

    Can We Use Ultrasound to Identify Rheumatoid Arthritis Patients in Remission Who Cannot Taper Their Medication?

    Myrthe van der Ven1, T. Martijn Kuijper1, A. H. Gerards2, Ilja Tchetverikov3, A.E.a.M. Weel1,4, D. van Zeben5, J.M.W. Hazes1 and J.J. Luime1, 1Rheumatology, Erasmus University Medical Center, Rotterdam, Netherlands, 2Rheumatology, Vlietland Hospital, Schiedam, Netherlands, 3Albert Schweitzer Ziekenhuis, Dordrecht, Netherlands, 4Department of Rheumatology, Maasstad Hospital, Rotterdam, Netherlands, 5Rheumatology, Sint Franciscus Gasthuis, Rotterdam, Netherlands

    Background/Purpose: Tapering medication in rheumatoid arthritis (RA) patients is becoming increasingly important due to the effectiveness of both biological therapy and tight-controlled treatment. Patients are…
  • Abstract Number: 119 • 2014 ACR/ARHP Annual Meeting

    Sonographic Evaluation of the Fifth Metatarsophalangeal Joint Erosion in Rheumatoid Arthritis

    Nevsun Inanc1, Gulsen Ozen1, Sibel Z. Aydin2, Esen Kasapoglu Gunal3 and Haner Direskeneli1, 1Department of Rheumatology, Marmara University School of Medicine, Istanbul, Turkey, 2Department of Rheumatology, Koc University Faculty of Medicine, Istanbul, Turkey, 3Department of Rheumatology, Goztepe Medeniyet University Faculty of Medicine, Istanbul, Turkey

    Background/Purpose: Joint erosions in RA correlate with structural damage progression and functional capacity. Therefore, detection and the follow-up of erosions are of paramount importance for…
  • Abstract Number: 98 • 2014 ACR/ARHP Annual Meeting

    Costs of Musculoskeletal Diseases in the United States, 1996-2011: Population Growth, Population Aging, Health Care Utilization, or Prices?

    Edward H. Yelin1, Miriam G. Cisternas2, Laura Trupin3 and Stuart Gansky4, 1Arthritis Research Group, University of California, San Francisco, San Francisco, CA, 2MGC Data Services, Carlsbad, CA, 3Medicine, University of California, San Francisco, San Francisco, CA, 4Preventive & Restorative Dental Sciences, University of California, San Francisco, San Francisco, CA

    Background/Purpose: Medical care costs have been a major concern for public policy for a generation. Concern about costs of musculoskeletal conditions (MUSC) has been fueled…
  • Abstract Number: 97 • 2014 ACR/ARHP Annual Meeting

    Identification of Tuberculosis in Rheumatoid Arthritis Patients Initiating Therapy with Biologic or Non-Biologic Disease-Modifying Anti-Rheumatic Drugs Using Health Insurance Claims Data

    T Simon1, N Liu2, N Baker3, N Lin2 and V Hoffman4, 1Bristol-Myers Squibb, Hopewell, NJ, 2Optum Epidemiology, Waltham, MA, 3Bristol-Myers Squibb, Hopewell, MA, 4Optum Epidemiology, Ann Arbor, MI

    Background/Purpose: Biologic DMARDs used for the treatment of RA may increase the risk of tuberculosis (TB).1 Large healthcare claims databases are useful in assessing rare…
  • « Previous Page
  • 1
  • …
  • 2041
  • 2042
  • 2043
  • 2044
  • 2045
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology